Personalized Medicine Outsourcing Market Trends: Comprehensive Overview
The global personalized medicine outsourcing market size was estimated at USD 112.08 billion in 2024 and is projected to grow at a CAGR of 12.47% from 2025 to 2030. The increasing awareness regarding benefits of personalized medicine, increasing application of personalized medicine in various diseases, such as rare diseases, cancer, infectious diseases, and others, the requirement of specialized expertise, and the benefits of outsourcing the services are some of the major factors driving the market growth. The increasing prevalence of diseases such as chronic diseases, rare diseases and infectious diseases is further increasing the demand for these medicines as it offers enhanced patient outcomes. According to the American Cancer Society report, Cancer Facts & Figures 2023, cancer was expected to cause around 609,820 deaths in the U.S. in 2023 and was expected to diagnose over 1.9 people in the same year.
Market Concentration & Characteristics
The market growth stage is medium, with an accelerating pace. The market is characterized by the level of M&A activities, degree of innovation, regulatory impact, product expansions, and regional expansions.
The market is experiencing significant degree of innovation, particularly in the development of advanced technologies such as next-generation sequencing and proteomics. These advancements are enhancing biomarker discovery and diagnostic accuracy, enabling more personalized treatment methods.
Regulatory frameworks play a fundamental role in influencing the market. Compliance with stringent guidelines enhances the safety and efficacy of personalized therapies, accelerating outsourcing strategies and partnerships.
The level of M&A activity in the market is moderate as companies seek to expand their technological capabilities, scale, and global footprint. Furthermore, larger firms acquire smaller, specialized manufacturers to enhance service portfolios. These strategic acquisitions majorly focus on expanding capabilities in personalized medicine solutions and gain a competitive edge in the market.
For More Details or Sample Copy please visit link @: Personalized Medicine Outsourcing Market Report
Recent Developments
In February 2024, Standard BioTools Inc. entered into a collaboration agreement with Navignostics AG to integrate Hyperion XTi Imaging System with personalized medicine service offerings and clinical research applications to offer crucial biological insights and guide treatment decisions.
In August 2021, Precision for Medicine and Trialbee, a patient enrollment platform, entered into a partnership that aims to utilize Trialbee’s advanced analytics to recruit and match patients to Precision for Medicine's trials, which can lead to the development of advanced, personalized medicine.
